Nursing experience of a breast cancer patient with diarrhea reaction after taking neratinib

Nursing experience of a breast cancer patient with diarrhea reaction after taking neratinib

Bibliographic Details
Main Authors:	BaoPing Luo, LingXia Kong, MeiJin Yuan
Format:	Article
Language:	English
Published:	Elsevier 2023-09-01
Series:	Asian Journal of Surgery
Subjects:	Her-2 Nilatinib Diarrhea Breast cancer Self-management
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958423004414

Similar Items

Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer
by: Arlene Chan, et al.
Published: (2023-02-01)

Antibiotic treatment targeting gram negative bacteria prevents neratinib-induced diarrhea in rats
by: Kate R. Secombe, et al.
Published: (2022-08-01)

Neratinib for HER2-positive breast cancer with an overlooked option
by: Liting Guo, et al.
Published: (2023-10-01)

Transglutaminase-2 mediates acquisition of neratinib resistance in metastatic breast cancer
by: Aparna Shinde, et al.
Published: (2022-06-01)

The calcium‐sensing receptor: A novel target for treatment and prophylaxis of neratinib‐induced diarrhea
by: Taras Lysyy, et al.
Published: (2019-10-01)

Case Report: Neratinib Therapy Improves Glycemic Control in a Patient With Type 2 Diabetes and Breast Cancer
by: Vasileios Angelis, et al.
Published: (2022-03-01)

Analysis of Gut Microbiome Using Explainable Machine Learning Predicts Risk of Diarrhea Associated With Tyrosine Kinase Inhibitor Neratinib: A Pilot Study
by: Chi Wah Wong, et al.
Published: (2021-03-01)

Exceptional disease control with neratinib monotherapy in HER2-positive advanced breast cancer: A case report
by: Pierluigi di Mauro, et al.
Published: (2022-06-01)

The Clinical Efficacy and Safety of Neratinib in Combination with Capecitabine for the Treatment of Adult Patients with Advanced or Metastatic HER2-Positive Breast Cancer
by: Chilà G, et al.
Published: (2021-06-01)

Preclinical Characteristics of the Irreversible Pan-HER Kinase Inhibitor Neratinib Compared with Lapatinib: Implications for the Treatment of HER2-Positive and <i>HER2</i>-Mutated Breast Cancer
by: Denis M. Collins, et al.
Published: (2019-05-01)

PI3K and MAPK Pathways as Targets for Combination with the Pan-HER Irreversible Inhibitor Neratinib in HER2-Positive Breast Cancer and TNBC by Kinome RNAi Screening
by: Jangsoon Lee, et al.
Published: (2021-06-01)

Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis
by: Aadya Nagpal, et al.
Published: (2019-08-01)

Diarrhea and breastfeeding in infants younger than six months
by: Yainet Rafaela Estrada-Tamayo, et al.
Published: (2018-09-01)

Nutritional and growth profile of infants with acute diarrhea presenting to diarrhea training unit in Kerman No.1 Hospital
by: M.H.Torabi – Nezhad (M.D), et al.
Published: (2000-03-01)

Is prevalence of diarrhea a better predictor of subsequent mortality and weight gain than diarrhea incidence? /
by: Morris, Saul S.
Published: (1996)

Incidence of diarrhea: poor parental recall ability
by: Maria Clotildes N. de Melo, et al.

Fructus mume Extracts Alleviate Diarrhea in Breast Cancer Patients Receiving the Combination Therapy of Lapatinib and Capecitabine
by: Hua Xing, et al.
Published: (2018-05-01)

Norovirus-specific immunoglobulin A in breast milk for protection against norovirus-associated diarrhea among infants
by: Hannah Karen Mina Labayo, et al.
Published: (2020-10-01)

Chronic diarrhea and skin hyperpigmentation: A new association
by: Al Qoaer Khaled, et al.
Published: (2008-01-01)

Probable topiramate-induced diarrhea in a 2-month-old breast-fed child — A case report
by: Tone Westergren, et al.
Published: (2014-01-01)

Treatment of traveler's diarrhea - clinical review
by: Karol Mazur, et al.
Published: (2020-05-01)

DIARRHEA: A CORRECT ALGORITHM OF DOCTOR’S ACTIONS
by: E. A. Belousova, et al.
Published: (2017-11-01)

Rifaximin for Pertuzumab-Related GI Toxicities
by: Aixa E. Soyano, et al.
Published: (2017-08-01)

Frequency of HER-2 over Expression in the Patients with Breast Cancer after Mastectomy
by: S kargar, et al.
Published: (2013-10-01)

The role of probiotics in the prevention and treatment of childhood infectious diarrhea
by: Maria Maragkoudaki, et al.
Published: (2013-10-01)

Evaluation of Human Epidermal Growth Factor Receptor-2 in Iraqi Women with Breast Cancer
by: Hiba Hadi Rashid, et al.
Published: (2019-06-01)

Evaluation of Human Epidermal Growth Factor Receptor-2 in Iraqi Women with Breast Cancer
by: Hiba Hadi Rashid, et al.
Published: (2019-06-01)

Survival outcomes in HER2-low versus HER2-zero breast cancer after neoadjuvant chemotherapy: a meta-analysis
by: Lin-Yu Xia, et al.
Published: (2024-04-01)

Persistent Diarrhea: Possible Risk Factors in Indonesia
by: Sunoto Sunoto
Published: (2019-01-01)

How I treat HER2-low advanced breast cancer
by: Ilana Schlam, et al.
Published: (2023-02-01)

Clinical characteristics and treatment outcomes of HER2 mutation and HER2 fusion in 22 patients with advanced breast cancer
by: Yuxin Mu, et al.
Published: (2023-12-01)

Self-limiting diarrhea in an infant exposed to sertraline in breast milk
by: N A Uvais
Published: (2017-01-01)

Prevalence of Clostridium Difficile- Associated Diarrhea in Hospitalized Patients with Nosocomial Diarrhea
by: N Sadeghifard, et al.
Published: (2005-09-01)

Profile of neratinib and its potential in the treatment of breast cancer
by: Feldinger K, et al.
Published: (2015-06-01)

Cholagenic diarrhea
by: A I Parfenov, et al.
Published: (2008-02-01)

Four variants of the pathogenesis of diarrhea and its therapy
by: E V Parfenov
Published: (2015-12-01)

Sticking to the Rules: Outcome and Success Rate of Guideline-Based Diarrhea Management in Metastatic Breast Cancer Patients Treated with Abemaciclib
by: Flavia Jacobs, et al.
Published: (2023-02-01)

A clinicopathological study and survival analysis of 99 breast cancers with HER2/CEP17 ratio ≥ 2.0 and an average HER2 copy number < 4.0 per cell in China
by: Shuling Zhou, et al.
Published: (2023-01-01)

Zinc therapy for different causes of diarrhea
by: Hafaz Zakky Abdillah, et al.
Published: (2013-12-01)

Selenium for acute watery diarrhea in children
by: Meiviliani Sinaga, et al.
Published: (2016-07-01)